Zaltidine

H2-receptor antagonist CAS# 85604-00-8

Zaltidine

2D Structure

Catalog No. BCC2068----Order now to get a substantial discount!

Product Name & Size Price Stock
Zaltidine: 5mg $299 In Stock
Zaltidine: 10mg Please Inquire In Stock
Zaltidine: 20mg Please Inquire Please Inquire
Zaltidine: 50mg Please Inquire Please Inquire
Zaltidine: 100mg Please Inquire Please Inquire
Zaltidine: 200mg Please Inquire Please Inquire
Zaltidine: 500mg Please Inquire Please Inquire
Zaltidine: 1000mg Please Inquire Please Inquire
Related Products
  • Ebrotidine

    Catalog No.:BCC1542
    CAS No.:100981-43-9

Quality Control of Zaltidine

3D structure

Package In Stock

Zaltidine

Number of papers citing our products

Chemical Properties of Zaltidine

Cas No. 85604-00-8 SDF Download SDF
PubChem ID 56051 Appearance Powder
Formula C8H10N6S M.Wt 222.27
Type of Compound N/A Storage Desiccate at -20°C
Solubility H2O : 7.69 mg/mL (34.60 mM; Need ultrasonic)
Chemical Name 2-[4-(2-methyl-1H-imidazol-5-yl)-1,3-thiazol-2-yl]guanidine
SMILES CC1=NC=C(N1)C2=CSC(=N2)N=C(N)N
Standard InChIKey GIMNAEMRNXUAQP-UHFFFAOYSA-N
Standard InChI InChI=1S/C8H10N6S/c1-4-11-2-5(12-4)6-3-15-8(13-6)14-7(9)10/h2-3H,1H3,(H,11,12)(H4,9,10,13,14)
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Zaltidine Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Zaltidine Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Zaltidine

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 4.499 mL 22.4952 mL 44.9903 mL 89.9807 mL 112.4758 mL
5 mM 0.8998 mL 4.499 mL 8.9981 mL 17.9961 mL 22.4952 mL
10 mM 0.4499 mL 2.2495 mL 4.499 mL 8.9981 mL 11.2476 mL
50 mM 0.09 mL 0.4499 mL 0.8998 mL 1.7996 mL 2.2495 mL
100 mM 0.045 mL 0.225 mL 0.4499 mL 0.8998 mL 1.1248 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on Zaltidine

Description: IC50 Value: N/A Zaltidine is a H2-receptor antagonist, which has the antisecretory action. in vitro: N/A in vivo: In eight healthy male volunteers single oral doses of 5 mg, 25 mg and 100 mg produced dose-related inhibition of basal and pentagastrin-stimulated acid output (M.A.O.) with an estimated ID50 of 40 mg for the latter. In eight subjects with duodenal ulceration single 100 mg and 200 mg doses produced 85% and 97% inhibition of M.A.O. at peak (3 h post-dose) and 20% and 23% inhibition at 24 h, respectively; inhibition of basal acid output was 97% at 3 h and 50% at 24 h with both doses [1]. One hundred and thirty-five patients were randomly allocated to 4 weeks' treatment with either 150 mg zaltidine once daily or placebo. Fifty-nine were treated for a full 4 weeks with zaltidine before the trial was stopped. Healing rates after 4 weeks of zaltidine and placebo were 86% and 19%, respectively (p less than 0.001) [2]. Clinical trial: N/A

Featured Products
New Products
 

References on Zaltidine

Zaltidine: an effective but hepatotoxic H2-receptor antagonist.[Pubmed:2902681]

Scand J Gastroenterol. 1988 Aug;23(6):655-8.

Zaltidine is a new H2-receptor antagonist. This study compares the safety and efficacy of Zaltidine with those of placebo in the short-term treatment of duodenal ulcer. One hundred and thirty-five patients were randomly allocated to 4 weeks' treatment with either 150 mg Zaltidine once daily or placebo. Fifty-nine were treated for a full 4 weeks with Zaltidine before the trial was stopped. Healing rates after 4 weeks of Zaltidine and placebo were 86% and 19%, respectively (p less than 0.001). Five patients in the Zaltidine group had increased serum aminotransferase levels at the final (4-week) visit. The values normalized when treatment was stopped. Liver biopsy specimens provide strong evidence of drug-induced injury. Hepatic damage was associated with plasma levels of Zaltidine in the upper half of the observed range. Zaltidine appears to be an effective treatment of duodenal ulcer. However, the incidence of hepatic damage (8%) seems higher than with commonly used H2-receptor antagonists.

The antisecretory effects of zaltidine, a novel long-acting H2-receptor antagonist, in healthy volunteers and in subjects with a past history of duodenal ulcer.[Pubmed:2876724]

Br J Clin Pharmacol. 1986 Oct;22(4):395-9.

The potency and duration of the antisecretory action of Zaltidine, a novel H2-receptor antagonist, have been examined in healthy volunteers and in patients with previous duodenal ulceration. In eight healthy male volunteers single oral doses of 5 mg, 25 mg and 100 mg produced dose-related inhibition of basal and pentagastrin-stimulated acid output (M.A.O.) with an estimated ID50 of 40 mg for the latter. In eight subjects with duodenal ulceration single 100 mg and 200 mg doses produced 85% and 97% inhibition of M.A.O. at peak (3 h post-dose) and 20% and 23% inhibition at 24 h, respectively; inhibition of basal acid output was 97% at 3 h and 50% at 24 h with both doses. The long duration of action of Zaltidine is ascribed to its relatively slow elimination from the plasma.

Description

Zaltidine(CP-57361) is a H2-receptor antagonist, which has the antisecretory action.

Keywords:

Zaltidine,85604-00-8,Natural Products,Histamine, buy Zaltidine , Zaltidine supplier , purchase Zaltidine , Zaltidine cost , Zaltidine manufacturer , order Zaltidine , high purity Zaltidine

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: